Pfizer (PFE) CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if necessary, as the Trump administration considers imposing tariffs on pharmaceuticals.
Read more...
Hence then, the article about pfizer ceo says the drugmaker is prepared to shift manufacturing to the us amid tariff threats was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer CEO says the drugmaker is prepared to shift manufacturing to the US amid tariff threats )
Also on site :
- Average fixed mortgage rates edge down but ‘too soon’ to signal a turning point
- Ampd Creates First to Market Frictionless Shopper Journey with the Launch of Agentic Shoppable Media
- Avalon Healthcare Solutions Recognized as USA TODAY Top Workplace